These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17971853)

  • 1. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
    Suwanarusk R; Russell B; Chavchich M; Chalfein F; Kenangalem E; Kosaisavee V; Prasetyorini B; Piera KA; Barends M; Brockman A; Lek-Uthai U; Anstey NM; Tjitra E; Nosten F; Cheng Q; Price RN
    PLoS One; 2007 Oct; 2(10):e1089. PubMed ID: 17971853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.
    Li J; Zhang J; Li Q; Hu Y; Ruan Y; Tao Z; Xia H; Qiao J; Meng L; Zeng W; Li C; He X; Zhao L; Siddiqui FA; Miao J; Yang Z; Fang Q; Cui L
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008255. PubMed ID: 32530913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
    Suwanarusk R; Chavchich M; Russell B; Jaidee A; Chalfein F; Barends M; Prasetyorini B; Kenangalem E; Piera KA; Lek-Uthai U; Anstey NM; Tjitra E; Nosten F; Cheng Q; Price RN
    J Infect Dis; 2008 Nov; 198(10):1558-64. PubMed ID: 18808339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.
    Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
    Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
    Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
    Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana.
    Faway E; Musset L; Pelleau S; Volney B; Casteras J; Caro V; Menard D; Briolant S; Legrand E
    Malar J; 2016 Nov; 15(1):540. PubMed ID: 27825387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
    Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
    Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
    Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination.
    Ngassa Mbenda HG; Wang M; Guo J; Siddiqui FA; Hu Y; Yang Z; Kittichai V; Sattabongkot J; Cao Y; Jiang L; Cui L
    Parasit Vectors; 2020 Feb; 13(1):67. PubMed ID: 32051017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
    Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
    Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.
    Shalini S; Chaudhuri S; Sutton PL; Mishra N; Srivastava N; David JK; Ravindran KJ; Carlton JM; Eapen A
    Malar J; 2014 Mar; 13():129. PubMed ID: 24685286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
    Chehuan YF; Costa MR; Costa JS; Alecrim MG; Nogueira F; Silveira H; Brasil LW; Melo GC; Monteiro WM; Lacerda MV
    Malar J; 2013 Jul; 12():226. PubMed ID: 23819884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China-Myanmar border during 2008‒2017.
    Wang Z; Wei C; Pan Y; Wang Z; Ji X; Chen Q; Zhang L; Wang Z; Wang H
    Infect Dis Poverty; 2022 Apr; 11(1):43. PubMed ID: 35462549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unlabelled probe-based real time PCR and modified semi-nested PCR as molecular tools for analysis of chloroquine resistant Plasmodium vivax isolates from Afghanistan.
    Mosawi SH; Dalimi A; Safi N; Fotouhi-Ardakani R; Ghaffarifar F; Sadraei J
    Malar J; 2020 Jul; 19(1):253. PubMed ID: 32664942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.